Evaluating Therapeutic Drug Monitoring in IBD

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Adam S. Cheifetz, MD Therapeutic drug monitoring has emerged as an important tool to optimize therapy for patients with inflammatory bowel disease (IBD). To help us learn more about this tool, Dr. Peter Buch is joined by Dr. Adam Cheifetz of Beth Israel Deaconess Medical Center and Professor of Medicine at Harvard Medical School.

Episode metadata supplied by the publisher feed · Published May 19, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Evaluating Therapeutic Drug Monitoring in IBD

0:00 12:00

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of GI Insights?

This episode is 12 minutes long.

When was this GI Insights episode published?

This episode was published on May 19, 2022.

Can I download this GI Insights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!